# Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
> **Product code: NHX** · Class II — Moderate Risk (510(k) clearance required) · Immunology · 21 CFR 866.5775
## Classification
- **FDA Product Code:** NHX
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 866.5775
- **Review panel:** IM
- **Medical specialty:** Immunology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** Y
## Definition

The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.

## Market data
- **Cleared 510(k) submissions:** 21
- **Registered establishments:** 23
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=NHX)
---
*AI Analytics · CC0 1.0*